GSK plc Files 6-K on Share Transaction

TL;DR

GSK plc filed a 6-K on 3/30/26 about a transaction in its own shares.

AI Summary

On March 30, 2026, GSK plc filed a Form 6-K with the SEC, reporting a transaction involving its own shares. The filing, with SEC Accession No. 0001654954-26-002914, was accepted on the same date. The document details a transaction in GSK's own shares.

Why It Matters

This filing indicates GSK plc is actively managing its own share capital, which could signal buybacks or other treasury share activities.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a transaction in the company's own shares, not indicating significant new risks.

Key Players & Entities

• GSK plc (company) — Filer of the 6-K report
• 0001131399 (company) — CIK number for GSK plc
• 0001654954-26-002914 (other) — SEC Accession Number for the filing
• 2026-03-30 (date) — Period of Report and Filing Date

FAQ

Filing Documents

• a5267y.htm (6-K) — 4412KB
• 0001654954-26-002914.txt ( ) — 4413KB

From the Filing

IN OWN SHARES a5267y UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of March 2026   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .       Transaction in own shares   GSK plc (the " Company ") announces today   acting through BNP Paribas SA (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.   Date of purchase: 27 March 2026 Aggregate number of ordinary shares of  31¼  pence each purchased: 340,000 Lowest price paid per share (GBp): 2,024.00p Highest price paid per share (GBp): 2,060.00p Volume-weighted average price paid per share (GBp): 2,043.51p   The purchased shares will be held   as Treasury shares.                                                                                                                            Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker, as announced on 17 February 2026. Since 17 February 2026, the Company has purchased 15,541,521 ordinary shares.   Following the above purchase, the Company will hold 255,432,615 ordinary shares in treasury and have 4,060,747,166 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,060,747,166. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is 6.29 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.   Schedule of Purchases Shares purchased:   GSK plc (ISIN: GB00BN7SWP63) Date of purchases:     27 March 2026 Investment firm:         BNP Paribas SA       Aggregated information per trading venue: Venue   Number of ordinary shares purchased   Highest price paid (per ordinary share)(GBp)   Lowest price paid (per ordinary share)(GBp)   Volume weighted average price paid (per ordinary share) (GBp)   BATE   56,267   2,059.00p   2,024.00p   2,043.18p   CHIX   106,264   2,060.00p   2,025.00p   2,043.32p   XLON   177,469   2,060.00p   2,024.00p   2,043.72p       Individual transactions:   Number of Shares   Price per Share (GBp)   Trading venue   Date of transaction   Time of transaction   Transaction reference number   47   2039.0   XLON   27-Mar-2026   08:00:12   20260327182286990   94   2039.0   XLON   27-Mar-2026   08:00:12   20260327182286992   144   2038.0   XLON   27-Mar-2026   08:00:28   20260327182288378   154   2041.0   XLON   27-Mar-2026   08:00:54   20260327182288685   22 &#xA

View Full Filing

View this 6-K filing on SEC EDGAR